BPC-157 (Body Protective Compound)

Category: compound

A synthetic pentadecapeptide derived from human gastric juice protein. Shows tissue repair, anti-inflammatory, and neuroprotective properties in preclinical models.

Mechanism Detail

BPC-157 upregulates growth factor receptors (VEGF-R2, EGF-R), modulates the nitric oxide system, and activates the JAK-2/STAT-3 signaling pathway. It promotes angiogenesis, accelerates wound healing, and demonstrates cytoprotective effects across organ systems including the CNS.

Clinical Status

Preclinical. No FDA-approved clinical trials for neurological conditions. Widely used in regenerative medicine research.

Relevant Diseases

• ALS
• Parkinson's Disease

Relevant Therapies

• Peptides

Related Terms

• TB-500
• Thymosin alpha-1
• Peptide therapy
• Neuroprotection